Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC lessened its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 15.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 242,923 shares of the company’s stock after selling 44,889 shares during the quarter. Nuveen Asset Management LLC owned 0.13% of Alignment Healthcare worth $2,733,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. RiverPark Advisors LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $106,000. Tower Research Capital LLC TRC grew its position in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares during the period. Aigen Investment Management LP purchased a new position in Alignment Healthcare in the fourth quarter valued at $129,000. AlphaQuest LLC acquired a new position in shares of Alignment Healthcare in the fourth quarter worth about $132,000. Finally, Dark Forest Capital Management LP acquired a new position in shares of Alignment Healthcare in the fourth quarter worth about $150,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on ALHC shares. Barclays upped their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research report on Friday, February 28th. UBS Group raised their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a “neutral” rating in a research note on Friday, May 2nd. JPMorgan Chase & Co. lifted their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Robert W. Baird increased their target price on Alignment Healthcare from $17.00 to $22.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. Finally, Stifel Nicolaus lifted their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average price target of $17.17.

Alignment Healthcare Trading Up 0.9%

Shares of ALHC stock opened at $15.51 on Tuesday. Alignment Healthcare, Inc. has a 12 month low of $7.05 and a 12 month high of $21.06. The company has a market cap of $3.07 billion, a PE ratio of -20.14 and a beta of 1.32. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The business’s 50 day moving average is $16.95 and its two-hundred day moving average is $14.74.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. During the same period in the previous year, the business earned ($0.25) EPS. The firm’s revenue was up 47.5% on a year-over-year basis. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Buying and Selling at Alignment Healthcare

In related news, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the firm’s stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the sale, the director now directly owns 44,302,175 shares in the company, valued at approximately $676,937,234. This trade represents a 27.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO John E. Kao sold 554,713 shares of Alignment Healthcare stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.53, for a total transaction of $8,614,692.89. Following the sale, the chief executive officer now directly owns 4,733,664 shares of the company’s stock, valued at $73,513,801.92. The trade was a 10.49% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,891,977 shares of company stock valued at $290,517,011. 7.00% of the stock is currently owned by insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.